Open Access<p>Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)</p>
Author(s) -
Kyung Soo Hong,
Min Cheol Kim,
JaeJun Ahn
Publication year - 2020
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s249534
Subject(s) - sarcopenia , medicine , national health and nutrition examination survey , copd , body mass index , odds ratio , gastroenterology , steatosis , nonalcoholic fatty liver disease , diabetes mellitus , fatty liver , metabolic syndrome , population , confidence interval , obesity , endocrinology , disease , environmental health
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in patients with chronic obstructive pulmonary disease (COPD) and is independently associated with cardiometabolic comorbidities and systemic inflammation. Although several factors are associated with NAFLD, the influence of sarcopenia on NAFLD has not been fully determined in patients with COPD. We explored whether sarcopenia is associated with NAFLD in a COPD population.